INS and type 2 diabetes mellitus: The results of the analysis for the different treatment modalities revealed that T2DM patients requiring antidiabetic drug therapy and insulin therapy had lower CBF in the four differential brain regions than non-drug therapy patients and T2DM patients requiring antidiabetic drug therapy had significantly lower CBF in the right insula than non-drug therapy patients (Figure 1B, P < 0.05).